Clinical Trial Update: Subcutaneous Median Nerve Neuromodulation For Drug-Treatment Resistant Hypertension. [NA]

View source ↗

Summary

A clinical trial investigating subcutaneous median nerve neuromodulation for drug-treated resistant hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• Subcutaneous Median Nerve Neuromodulation Device

Snippet

Sponsor: Valencia Technologies Corporation | Conditions: Resistant Hypertension | NA | Status: WITHDRAWN